Lionsgate Poison Pill Invalidated by Canadian Regulators

Lionsgate ($LGF) is trading north of 7 this morning on news that regulators in British Columbia have invalidated a poison pill that the company had hoped would fend off Carl Icahn

April 30th at 8pm is the deadline for shareholders to take Icahn up on his offer.  Analysts believe that Icahn will have to extend his deadline for the $7 a share tender and he may have to up his bid…

From BusinessWeek:

“Icahn goes forward and tries to buy the firm,” said Alan Gould, an analyst with Soleil Securities in New York. “To get over 50 percent of the company, he clearly has to go over $7 a share.”

From Icahn’s press release (WSJ):

Carl C. Icahn today announced that the British Columbia Securities Commission (BCSC), the independent provincial government agency responsible for regulating securities trading in British Columbia, has issued a “cease trade order” with respect to the Poison Pill adopted by Lions Gate’s board of directors, effectively eradicating the Pill and restoring to shareholders the right to decide for themselves – without interference from the Board – whether they wish to participate in the Icahn Group’s tender offer.

Carl C. Icahn reacted to the BCSC’s decision by commenting: “I am gratified to see that – consistent with its vision to play a leading role in securities regulation that inspires investor confidence and supports fair, efficient, and innovative Canadian capital markets – the BCSC agreed with our view that Lions Gate shareholders should have the right to decide for themselves whether they wish to sell their shares in our tender offer. We commend the Commission for its thoughtful consideration and resolution of this important issue.”

Lionsgate says they will appeal the decision of their jurisdictional regulator, but the clock is ticking.  They believe the poison pill is necessary to protect shareholders from having their company taken from them for an unfair price.

Some related reading:


Lions Gate Poison Pill Annulled by Canadian Regulator (BusinessWeek)

This content, which contains security-related opinions and/or information, is provided for informational purposes only and should not be relied upon in any manner as professional advice, or an endorsement of any practices, products or services. There can be no guarantees or assurances that the views expressed here will be applicable for any particular facts or circumstances, and should not be relied upon in any manner. You should consult your own advisers as to legal, business, tax, and other related matters concerning any investment.

The commentary in this “post” (including any related blog, podcasts, videos, and social media) reflects the personal opinions, viewpoints, and analyses of the Ritholtz Wealth Management employees providing such comments, and should not be regarded the views of Ritholtz Wealth Management LLC. or its respective affiliates or as a description of advisory services provided by Ritholtz Wealth Management or performance returns of any Ritholtz Wealth Management Investments client.

References to any securities or digital assets, or performance data, are for illustrative purposes only and do not constitute an investment recommendation or offer to provide investment advisory services. Charts and graphs provided within are for informational purposes solely and should not be relied upon when making any investment decision. Past performance is not indicative of future results. The content speaks only as of the date indicated. Any projections, estimates, forecasts, targets, prospects, and/or opinions expressed in these materials are subject to change without notice and may differ or be contrary to opinions expressed by others.

Wealthcast Media, an affiliate of Ritholtz Wealth Management, receives payment from various entities for advertisements in affiliated podcasts, blogs and emails. Inclusion of such advertisements does not constitute or imply endorsement, sponsorship or recommendation thereof, or any affiliation therewith, by the Content Creator or by Ritholtz Wealth Management or any of its employees. Investments in securities involve the risk of loss. For additional advertisement disclaimers see here:

Please see disclosures here.

What's been said:

Discussions found on the web
  1. Eat Verts commented on Sep 22

    … [Trackback]

    […] Read More on on that Topic: […]

  2. immediate edge review commented on Sep 22

    … [Trackback]

    […] Read More Info here on that Topic: […]

  3. bitcoin era review 2020 commented on Sep 23

    … [Trackback]

    […] Find More to that Topic: […]

  4. blazing trader commented on Sep 27

    … [Trackback]

    […] Read More Info here on that Topic: […]

  5. dragon pharma oral tren commented on Oct 08

    … [Trackback]

    […] Read More Information here to that Topic: […]

  6. realistic wig commented on Jan 07

    … [Trackback]

    […] Info to that Topic: […]

  7. manulife client login commented on Jan 14

    … [Trackback]

    […] Read More on that Topic: […]

  8. tangerine online banking sign in commented on Jan 17

    … [Trackback]

    […] Read More on on that Topic: […]